Physician

Matthew Peter Campbell, MD

According to 2025 Medicare claims, Matthew Campbell, MD (NPI: 1083735070) practices vascular surgery in the Visalia, CA market, with the plurality of this provider's patient population coming from Tulare, CA. This provider's primary affiliated billing organization is BASS MEDICAL GROUP (NPI: 1154401941; TIN: 562605608) and primary practice location at 93277-8306. Campbell is affiliated with the Aledade 45 CA CHC MSSP Enhanced (ACO ID: A4542), Aledade 60 CA MSSP Enhanced (ACO ID: A4775), and Privia Quality Network Tennessee, LLC (ACO ID: A4943), participating under the MSSP model.

Campbell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 976 traditional Medicare patients, billed 4,439 HCPCS/CPT codes, and received $429,575 in Medicare payments. The top billing code was 93925 (Ultrasound of leg arteries or artery grafts). Part D data shows 145 prescription claims across 61 beneficiaries totaling $35,309 in drug costs, led by Xarelto (Rivaroxaban). 2016 DME data shows 295 claims. Open Payments data shows 5 records totaling $102. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $1,069,259 to $429,575. In contrast, Part D prescription costs have moved sharply higher in recent years, from $6,903 to $35,309. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,159	13,046	$1,069,259
2016	1,105	18,898	$1,573,424
2017	1,116	11,693	$903,049
2018	838	7,551	$649,051
2019	1,110	7,453	$738,416
2020	818	6,099	$546,429
2021	701	4,121	$403,685
2022	951	4,000	$461,762
2023	876	5,154	$455,029
2024	976	4,439	$429,575

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	171	301	$6,903
2016	160	323	$7,112
2017	160	372	$7,365
2018	137	282	$4,630
2019	145	306	$11,358
2020	99	201	$23,316
2021	80	203	$39,030
2022	79	167	$34,915
2023	88	189	$52,858
2024	61	145	$35,309

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	307	524	$115,891
2016	155	295	$32,275
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93925	Ultrasound of leg arteries or artery grafts	220	235	$191
93970	Ultrasound study of arm or leg veins with compression and maneuvers	136	136	$150
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	112	112	$129
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	144	176	$98
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	419	662	$68

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	29	1,650	$29,550
Cilostazol	Cilostazol	35	2,805	$823
Clopidogrel	Clopidogrel Bisulfate	29	2,283	$328
Tramadol Hcl	Tramadol Hcl	13	110	$25

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$102	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew Peter Campbell, MD?

Tedicare shows public-source Medicare data for Matthew Peter Campbell, MD (NPI 1083735070), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Peter Campbell, MD have ACO affiliation data?

Matthew Peter Campbell, MD is shown with ACO affiliation data for Aledade 45 CA CHC MSSP Enhanced (MSSP, ACO ID A4542), Aledade 60 CA MSSP Enhanced (MSSP, ACO ID A4775), and Privia Quality Network Tennessee, LLC (MSSP, ACO ID A4943).

What billing organization is linked to Matthew Peter Campbell, MD?

Matthew Peter Campbell, MD is linked to BASS MEDICAL GROUP (billing NPI 1154401941) in the available physician profile data.

Does Matthew Peter Campbell, MD have Open Payments data?

Matthew Peter Campbell, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.